Finance
Markets
No recent trading data. The last price we hold for GEHC is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

GEHC

stock Healthcare Medical Devices
GE HealthCare
$62.03 +0.04 (+0.06%) Delayed · quoted 47d ago
Mixed 50% Steady

What the indicators say

Bearish 0 of 5 trend signals bullish
Momentum · RSI 14 Leaning bearish
41
0oversold 30overbought 70100

RSI 41 — soft momentum, not yet oversold.

EMA 21 $63.43
Below
Near-term trend is down
SMA 50 $66.93
Below
Medium-term trend is down
SMA 200 $75.18
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $66.60
Downtrend
Price is below the Supertrend band — bearish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $60.74 High $62.11
Open
$62.03
+0.06%
Close
$62.03
+0.06%
52-week range where the price sits across its year
52w low $58.75 52w high $89.77
Current
$62.03
Prev close
$61.99
Volume 0.83× the 3-month average
0 avg 2× avg
Today
3.92M
3-mo avg
4.72M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 2983 days ago
Next expected
Jul 29in 8 days

Recent earnings dates

  • Apr 29 83 days ago
  • Feb 4 167 days ago
  • Oct 29, 2025 265 days ago
  • Jul 30, 2025 356 days ago

Past earnings dates come from GEHC’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Fair

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), GEHC’s fundamentals read as fair overall.

P/E ratio Strong
14.9x

At 14.9x, the price is a reasonable multiple of the company's annual profit.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.23%

A 0.2% yield is modest: a small income on top of whatever the share price does.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
10.1%

A 10.1% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Strong
20.1%

A 20.1% return on equity is strong; the company compounds owners' capital well.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
5.6%

A 5.6% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Weak
2.53

At 2.53, the company leans heavily on borrowing, which adds risk if results weaken.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Fair
1.37

At 1.37, short-term assets cover short-term bills with a little room to spare.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+4.8%

Revenue grew 4.8% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Fair
+4.6%

Net income grew 4.6% from the prior year: steady profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $17.6B$18.3B$19.6B$19.7B$20.6B
Net income $2.2B$1.9B$1.6B$2.0B$2.1B
Diluted EPS $4.95$4.22$3.03$4.34$4.55
Dividend / share $0.12$0.12$0.14
Total assets $27.5B$32.5B$33.1B$36.9B
Total liabilities $17.9B$25.1B$24.4B$26.3B
Shareholder equity $16.7B$9.4B$7.1B$8.4B$10.4B

Leadershipsynced from SEC 56d ago

  • Bankes Jeannette CEO, Patient Care Solutions
  • Rackliffe Philip CEO, AIS
  • Culp H Lawrence Jr Director
  • Hochman Rodney F Director
  • Lesjak Catherine A Director
  • Lobo Kevin Director
  • Madden Anne T Director
  • Stromberg William J Director
  • Yang Watkin Phoebe L. Director

Officers and board are drawn from GEHC’s recent SEC ownership filings (Forms 3, 4 and 5).

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Fair
2025 total
$0.14
2026 so far
$0.072 payments
2026 projected
$0.14+0.0% vs 2025

Projection scales GEHC’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • Apr 2 $0.04
  • Jan 9 $0.04
  • Oct 24, 2025 $0.04
  • Jul 25, 2025 $0.04
  • Apr 25, 2025 $0.04
  • Jan 14, 2025 $0.04
  • Oct 18, 2024 $0.03
  • Jul 19, 2024 $0.03
  • Apr 18, 2024 $0.03
  • Jan 12, 2024 $0.03
  • Oct 19, 2023 $0.03
  • Jul 20, 2023 $0.03
  • May 22, 2023 $0.03

Recent SEC filingssynced from SEC 51d ago